REQUEST A DEMO
Total
USD $0.00
Search more companies

Centrul De Oncologie Sf Nectarie SRL (Romania)

Main Activities: General Medical and Surgical Hospitals
Full name: Centrul De Oncologie Sf Nectarie SRL Profile Updated: July 26, 2018
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English & Romanian Download a sample report

Centrul De Oncologie Sf Nectarie SRL is an enterprise in Romania, with the main office in CARCEA. It operates in the General Medical and Surgical Hospitals industry. The company was established on December 02, 2013. It currently has a total number of 38 (2017) employees. From the latest financial highlights, Centrul De Oncologie Sf Nectarie SRL reported a net sales revenue increase of 34.46% in 2018. Its’ total assets recorded a growth of 85.7%. The net profit margin of Centrul De Oncologie Sf Nectarie SRL decreased by 2.26% in 2018.

Headquarters
Strada Stefan Cel Mare Nr. 13
CARCEA; Dolj; Postal Code: 207206

Contact Details: Purchase the Centrul De Oncologie Sf Nectarie SRL report to view the information.

Basic Information
Total Employees:
Purchase the Centrul De Oncologie Sf Nectarie SRL report to view the information.
Registered Capital:
Purchase the Centrul De Oncologie Sf Nectarie SRL report to view the information.
Incorporation Date:
December 02, 2013
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Centrul De Oncologie Sf Nectarie SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
34.46%
Total operating revenue
28.75%
Operating profit (EBIT)
17.42%
EBITDA
17.18%
Net Profit (Loss) for the Period
16.63%
Total assets
85.7%
Total equity
16.63%
Operating Profit Margin (ROS)
-2.52%
Net Profit Margin
-2.26%
Return on Equity (ROE)
0%
Quick Ratio
-0.08%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?